Sanofi Pharma Ltd. | Mutual Funds

Mutual Funds that own Sanofi Pharma Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
PineBridge Mauritius (GF) Ltd.
693,544
3.01%
16,152
4.18%
12/31/2017
Aberdeen Global - Indian Equity Fund
525,050
2.27%
-66,599
2.08%
05/31/2018
Birla Sun Life Frontline Equity Fund
481,807
2.09%
0
1.41%
07/31/2018
Franklin India High Growth Companies Fund
287,647
1.25%
-12,353
2.33%
08/31/2018
Reliance Pharma Fund
281,939
1.22%
0
6.9%
08/31/2018
Aberdeen Global - Asian Smaller Companies Fund
274,384
1.19%
-84,335
1.64%
05/31/2018
Reliance Growth Fund
205,556
0.89%
0
1.88%
08/31/2018
SBI Magnum Mid Cap Fund
194,915
0.85%
0
3.29%
06/30/2018
UTI - Mastershare Unit Scheme
169,200
0.74%
-1,800
1.87%
08/31/2018
Aberdeen India Fund
169,170
0.74%
-38,800
1.8%
03/31/2018

About Sanofi Pharma

View Profile
Address
Sanofi House
Mumbai Maharashtra 400072
India
Employees -
Website http://www.sanofiindialtd.com
Updated 09/14/2018
Sanofi India Ltd. engages in the manufacture and distribution of pharmaceutical drugs. The firm offers its products under the AllStar, Amaryl M, Amaryl M Forte, Amaryl MV, Apidra, Arava, Augeoz, Brodactam, Cardace, Cardace Protect, Cardace AM, Cardace Meto, Caspercid, Cetapin P, Cetapin XR, Cetapin V, Clexane, Daonil, Daonil M, Frisium, Insuman Rapid, Insuman Comb 25, Insuman Comb 50, Lantus, Lasilactone 50 Lasix, Metosan XR, M-Nem, Rejusite, Amaryl, Semi-Daonil, Targocid, Taxotere, Telsite, Telsite AM, Telsite AM H, Telsite H, Trental, Vogsite Md, and Zolineg brands. It also focuses on the following therapeutic areas: diabetes, cardiology, consumer healthcare, hospital, central nervous system, and anti-histamines.